RHOH and acute myeloid leukemia: Taken together, these considerations indicate that RHOH induction is a driver of terminal differentiation and might represent a means of AML treatment analogous to the differentiation therapy effected by all‐trans retinoic acid on the acute promyelocytic subtype [58].